| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 6.54e-05 | 2 | 162 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 6.54e-05 | 2 | 162 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | chromatin binding | FLI1 ASXL1 HDAC5 STAG1 RBBP4 CHAF1A ASH1L PAF1 KAT7 JARID2 BRCA1 UBE2T ASXL3 ATAD2B POLQ TASOR ZNF445 | 1.10e-04 | 739 | 162 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | oncostatin-M receptor activity | 1.95e-04 | 3 | 162 | 2 | GO:0004924 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CTTNBP2 ANK2 MAP1A MAP2 EPB41L5 ARFGEF1 ADGRV1 SHROOM2 CEACAM1 CCDC66 DLC1 ALMS1 BRCA1 PLEKHM2 STARD9 MYO3B SYNE2 CEP295 BRSK1 USH2A EPB41L1 | 2.27e-04 | 1099 | 162 | 21 | GO:0008092 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 4.82e-08 | 26 | 165 | 6 | GO:0046599 | |
| GeneOntologyBiologicalProcess | centriole replication | 8.87e-08 | 47 | 165 | 7 | GO:0007099 | |
| GeneOntologyBiologicalProcess | centriole assembly | 2.09e-07 | 53 | 165 | 7 | GO:0098534 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 2.77e-07 | 81 | 165 | 8 | GO:0051298 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 3.59e-06 | 52 | 165 | 6 | GO:0010824 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | PLK2 MAP1A STAG1 MAP2 IFT172 VPS4B STIL AXIN1 DNAAF2 PHLDB1 C2CD3 CCDC66 ALMS1 BRCA1 STARD9 SYNE2 CEP295 TACC3 BRSK1 | 5.24e-06 | 720 | 165 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 1.11e-05 | 63 | 165 | 6 | GO:0046605 | |
| GeneOntologyBiologicalProcess | centriole elongation | 2.73e-05 | 8 | 165 | 3 | GO:0061511 | |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 ASXL1 HDAC5 RBBP4 CHAF1A ASH1L ZDBF2 AXIN1 IWS1 KAT7 JARID2 KMT2C BRD8 ZZZ3 BRCA1 ARID2 ATAD2B EPC1 TASOR ZNF445 | 3.33e-05 | 896 | 165 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | microtubule-based process | PLK2 SPEM3 MAP1A STAG1 MAP2 IFT172 VPS4B ASH1L STIL AXIN1 DNAAF2 PHLDB1 C2CD3 CCDC66 ALMS1 BRCA1 STARD9 SYNE2 KATNIP CEP295 TACC3 BRSK1 | 3.83e-05 | 1058 | 165 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of centriole replication | 4.08e-05 | 9 | 165 | 3 | GO:0046601 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 5.37e-05 | 164 | 165 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | TET2 HDAC5 ZDBF2 AXIN1 KAT7 JARID2 BRCA1 ATAD2B EPC1 TASOR ZNF445 | 7.34e-05 | 330 | 165 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 HDAC5 RBBP4 CHAF1A ASH1L ZDBF2 AXIN1 IWS1 KAT7 JARID2 KMT2C BRCA1 ARID2 ATAD2B EPC1 TASOR ZNF445 | 9.65e-05 | 741 | 165 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 9.92e-05 | 179 | 165 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 1.29e-04 | 293 | 165 | 10 | GO:0032886 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 1.39e-04 | 188 | 165 | 8 | GO:0000724 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TET2 ASXL1 HDAC5 RBBP4 CHAF1A ASH1L ZDBF2 AXIN1 IWS1 KAT7 JARID2 KMT2C BRD8 ZZZ3 BRCA1 ARID2 ATAD2B EPC1 TASOR ZNF445 | 1.48e-04 | 999 | 165 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | recombinational repair | 1.73e-04 | 194 | 165 | 8 | GO:0000725 | |
| GeneOntologyBiologicalProcess | protein localization to heterochromatin | 1.90e-04 | 3 | 165 | 2 | GO:0097355 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MAP1A MAP2 VPS4B ARFGEF1 STIL SHROOM2 PHLDB1 DLC1 ALMS1 BRCA1 MYO3B CEP295 CGNL1 TACC3 | 2.39e-04 | 579 | 165 | 14 | GO:0051493 |
| GeneOntologyBiologicalProcess | axis specification | 2.98e-04 | 113 | 165 | 6 | GO:0009798 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 3.78e-04 | 4 | 165 | 2 | GO:0002017 | |
| GeneOntologyBiologicalProcess | oncostatin-M-mediated signaling pathway | 3.78e-04 | 4 | 165 | 2 | GO:0038165 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 3.92e-05 | 78 | 168 | 6 | GO:0001917 | |
| GeneOntologyCellularComponent | microtubule organizing center | RAB23 HORMAD2 PLK2 IFT172 VPS4B ANKRD26 IRS1 DENND1C STIL DNAAF2 EYS C2CD3 CCDC66 ALMS1 BRCA1 STARD9 CEP295 TACC3 BRSK1 USH2A | 5.11e-05 | 919 | 168 | 20 | GO:0005815 |
| GeneOntologyCellularComponent | oncostatin-M receptor complex | 6.42e-05 | 2 | 168 | 2 | GO:0005900 | |
| GeneOntologyCellularComponent | CAF-1 complex | 1.92e-04 | 3 | 168 | 2 | GO:0033186 | |
| GeneOntologyCellularComponent | USH2 complex | 3.81e-04 | 4 | 168 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | PR-DUB complex | 3.81e-04 | 4 | 168 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | primary dendrite | 3.81e-04 | 4 | 168 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ASXL1 RANBP2 HDAC5 RBBP4 RNPC3 VPS4B DDX42 ARFGEF1 XPC PAF1 HELB KAT7 JARID2 KMT2C GTF2H2 BRD8 BRCA1 ASXL3 ARID2 SYNE2 NPAP1 GINS2 SRRM2 | 6.78e-04 | 1377 | 168 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | transferase complex | RANBP2 TANK RBBP4 IRS1 REV3L PAF1 RNF11 CEACAM1 KAT7 JARID2 KMT2C TRMT6 GTF2H2 BRD8 ZZZ3 BRCA1 EPC1 NAA16 | 7.66e-04 | 963 | 168 | 18 | GO:1990234 |
| GeneOntologyCellularComponent | PcG protein complex | 8.07e-04 | 52 | 168 | 4 | GO:0031519 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 9.17e-04 | 139 | 168 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 9.43e-04 | 6 | 168 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 9.43e-04 | 6 | 168 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 9.43e-04 | 6 | 168 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 9.43e-04 | 6 | 168 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | ciliary basal body | 1.03e-03 | 195 | 168 | 7 | GO:0036064 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.07e-03 | 254 | 168 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | dendritic branch | 1.31e-03 | 7 | 168 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | centrosome | RAB23 HORMAD2 PLK2 VPS4B ANKRD26 DENND1C STIL EYS C2CD3 CCDC66 ALMS1 BRCA1 CEP295 TACC3 BRSK1 | 1.42e-03 | 770 | 168 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.50e-03 | 153 | 168 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.53e-03 | 104 | 168 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.74e-03 | 8 | 168 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.88e-03 | 109 | 168 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | female germ cell nucleus | 1.94e-03 | 31 | 168 | 3 | GO:0001674 | |
| GeneOntologyCellularComponent | centriole | 2.71e-03 | 172 | 168 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | Flemming body | 3.00e-03 | 36 | 168 | 3 | GO:0090543 | |
| HumanPheno | Trigonocephaly | 1.43e-05 | 45 | 62 | 6 | HP:0000243 | |
| HumanPheno | Abnormal external nose morphology | RAB23 RALGAPA1 FLI1 ASXL1 NEXMIF ASH1L EXT1 XPC STIL FREM1 AXIN1 JARID2 C2CD3 BRCA1 COG1 ASXL3 ARID2 KATNIP CEP295 EXOC2 SRRM2 SPEN CD96 IL6ST KNL1 | 2.86e-05 | 916 | 62 | 25 | HP:0010938 |
| HumanPheno | Upslanted palpebral fissure | ASXL1 STIL JARID2 C2CD3 BRCA1 UBE2T COG1 ASXL3 NPAP1 CEP295 EXOC2 SPEN CD96 KNL1 | 3.25e-05 | 333 | 62 | 14 | HP:0000582 |
| HumanPheno | Thin vermilion border | NEXMIF ZNF407 EXT1 STIL BRCA1 COG1 ASXL3 ARID2 NPAP1 CEP295 EXOC2 BRAT1 SRRM2 SPEN CD96 KNL1 | 3.93e-05 | 433 | 62 | 16 | HP:0000233 |
| HumanPheno | Thin upper lip vermilion | NEXMIF ZNF407 EXT1 STIL BRCA1 COG1 ASXL3 ARID2 NPAP1 CEP295 EXOC2 SRRM2 SPEN KNL1 | 3.96e-05 | 339 | 62 | 14 | HP:0000219 |
| HumanPheno | Thin lips | NEXMIF ZNF407 EXT1 STIL BRCA1 COG1 ASXL3 ARID2 NPAP1 CEP295 EXOC2 SRRM2 SPEN KNL1 | 3.96e-05 | 339 | 62 | 14 | HP:0000213 |
| HumanPheno | Abnormal consumption behavior | TET2 FLI1 ASXL1 CYP11B1 NEXMIF CYP11B2 ASH1L ALMS1 BRCA1 ARID2 NPAP1 SRRM2 SPEN | 4.62e-05 | 299 | 62 | 13 | HP:0040202 |
| HumanPheno | Precocious puberty | 6.81e-05 | 186 | 62 | 10 | HP:0000826 | |
| HumanPheno | Early onset of sexual maturation | 7.80e-05 | 189 | 62 | 10 | HP:0100000 | |
| HumanPheno | Thick eyebrow | 8.60e-05 | 154 | 62 | 9 | HP:0000574 | |
| HumanPheno | Abnormality of upper lip vermillion | NEXMIF ZNF407 EXT1 STIL JARID2 BRCA1 COG1 ASXL3 ARID2 NPAP1 CEP295 EXOC2 BRAT1 SRRM2 SPEN KNL1 | 9.13e-05 | 464 | 62 | 16 | HP:0011339 |
| MousePheno | abnormal urine progesterone level | 8.98e-05 | 2 | 133 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 8.98e-05 | 2 | 133 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 8.98e-05 | 2 | 133 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 8.98e-05 | 2 | 133 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 8.98e-05 | 2 | 133 | 2 | MP:0011546 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | RAB23 FLI1 IFT172 VPS4B DDX42 EPB41L5 STIL REV3L AXIN1 DNAAF2 KAT7 JARID2 C2CD3 PTPRB DLC1 BRCA1 ARID2 TACC3 | 1.12e-04 | 700 | 133 | 18 | MP:0011098 |
| Domain | FERM_C | 6.69e-05 | 26 | 160 | 4 | PF09380 | |
| Domain | Cyt_P450_mitochondrial | 7.29e-05 | 2 | 160 | 2 | IPR002399 | |
| Domain | FERM_PH-like_C | 7.81e-05 | 27 | 160 | 4 | IPR018980 | |
| Domain | FERM_C | 7.81e-05 | 27 | 160 | 4 | SM01196 | |
| Domain | FERM_N | 1.75e-04 | 33 | 160 | 4 | IPR018979 | |
| Domain | FERM_N | 1.75e-04 | 33 | 160 | 4 | PF09379 | |
| Domain | HARE-HTH | 2.18e-04 | 3 | 160 | 2 | PF05066 | |
| Domain | ASXH | 2.18e-04 | 3 | 160 | 2 | PF13919 | |
| Domain | PHD_3 | 2.18e-04 | 3 | 160 | 2 | PF13922 | |
| Domain | DUF4683 | 2.18e-04 | 3 | 160 | 2 | PF15735 | |
| Domain | ASX-like_PHD | 2.18e-04 | 3 | 160 | 2 | IPR026905 | |
| Domain | ASXH | 2.18e-04 | 3 | 160 | 2 | IPR028020 | |
| Domain | ALMS_motif | 2.18e-04 | 3 | 160 | 2 | IPR029299 | |
| Domain | ASX/ASX-like | 2.18e-04 | 3 | 160 | 2 | IPR024811 | |
| Domain | DUF4683 | 2.18e-04 | 3 | 160 | 2 | IPR032757 | |
| Domain | ALMS_motif | 2.18e-04 | 3 | 160 | 2 | PF15309 | |
| Domain | HB1/Asxl_HTH | 2.18e-04 | 3 | 160 | 2 | IPR007759 | |
| Domain | PH_dom-like | RANBP2 IRS4 EPB41L5 IRS1 PLEKHA6 WDFY4 PHLDB1 MTMR4 PTPN13 PTPN14 PLEKHM2 EPB41L1 | 3.13e-04 | 426 | 160 | 12 | IPR011993 |
| Domain | - | RANBP2 IRS4 EPB41L5 IRS1 PLEKHA6 PHLDB1 MTMR4 PTPN13 PTPN14 PLEKHM2 EPB41L1 | 5.64e-04 | 391 | 160 | 11 | 2.30.29.30 |
| Domain | FERM_M | 6.40e-04 | 46 | 160 | 4 | PF00373 | |
| Domain | - | 8.14e-04 | 49 | 160 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 8.14e-04 | 49 | 160 | 4 | IPR019748 | |
| Domain | FERM_domain | 8.14e-04 | 49 | 160 | 4 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 8.79e-04 | 50 | 160 | 4 | IPR014352 | |
| Domain | FERM_1 | 8.79e-04 | 50 | 160 | 4 | PS00660 | |
| Domain | FERM_2 | 8.79e-04 | 50 | 160 | 4 | PS00661 | |
| Domain | FERM_3 | 8.79e-04 | 50 | 160 | 4 | PS50057 | |
| Domain | Band_41_domain | 8.79e-04 | 50 | 160 | 4 | IPR019749 | |
| Domain | B41 | 8.79e-04 | 50 | 160 | 4 | SM00295 | |
| Domain | FERM_CS | 1.09e-03 | 24 | 160 | 3 | IPR019747 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.49e-03 | 7 | 160 | 2 | IPR003529 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 TET2 PLK2 IRS4 MAP2 EXPH5 MATR3 ANKRD26 EPB41L5 CRTC1 IRS1 STIL STOX2 PHLDB1 C2CD3 MTMR4 PTPN13 PTPN14 DLC1 ALMS1 PRRC2C STARD9 SYNE2 CNKSR3 ZBTB21 CGNL1 MAPK4 SRRM2 EPB41L1 GOLGB1 CCSER1 | 3.33e-18 | 861 | 170 | 31 | 36931259 |
| Pubmed | TET2 USP34 CASP8AP2 RANBP2 IRS4 HDAC5 VPS4B CRTC1 ZDBF2 PTPN13 ZZZ3 ALMS1 ZBTB21 TACC3 TASOR GOLGB1 KNL1 | 3.13e-11 | 418 | 170 | 17 | 34709266 | |
| Pubmed | RANBP2 IRS4 EXPH5 MATR3 ANKRD26 EPB41L5 AXIN1 STOX2 PTPN13 PTPN14 ALMS1 ZNF638 GOLGB1 | 6.81e-10 | 263 | 170 | 13 | 34702444 | |
| Pubmed | USP34 ZBTB2 MAP1A RBBP4 CHAF1A BTBD18 AOX1 ASH1L XPC REV3L KAT7 FAT1 BRD8 PTPN14 ZZZ3 ALMS1 BRCA1 ARID2 EPC1 ZBTB21 CEP295 OSMR SRRM2 KNL1 | 1.28e-09 | 1116 | 170 | 24 | 31753913 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CASP8AP2 HDAC5 MAP1A RBBP4 ANKRD26 ZDBF2 PAF1 PTPN14 ZZZ3 ALMS1 PRRC2C ARID2 CGNL1 SPEN GOLGB1 KNL1 | 5.59e-09 | 588 | 170 | 17 | 38580884 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 IRS4 ANK2 MAP1A MATR3 DDX42 ANKRD26 PAF1 AKAP12 PTPN13 ALMS1 PRRC2C ARID2 ZBTB21 ZNF638 PRR14L CGNL1 TASOR GOLGB1 KNL1 | 3.67e-08 | 934 | 170 | 20 | 33916271 |
| Pubmed | RANBP2 IRS4 ANK2 STAG1 CHAF1A MATR3 DDX42 ASH1L ANKRD26 XPC SH3D21 C2CD3 MIA2 BRCA1 COG1 PRRC2C STARD9 SYNE2 CNKSR3 ZBTB21 CEP295 POLQ SPEN TASOR GOLGB1 | 4.05e-08 | 1442 | 170 | 25 | 35575683 | |
| Pubmed | RAB23 USP34 MCAM ANKRD26 EPB41L5 ARFGEF1 MUC16 AKAP12 FAT1 PTPN13 BRCA1 PLEKHM2 ZNF638 CGNL1 TACC3 SPEN TASOR GOLGB1 | 5.76e-08 | 777 | 170 | 18 | 35844135 | |
| Pubmed | RANBP2 HDAC5 RBBP4 CHAF1A HELB IWS1 KAT7 JARID2 KMT2C ALMS1 PRRC2C ZNF638 SPEN TASOR | 8.92e-08 | 469 | 170 | 14 | 27634302 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RAB23 RALGAPA1 ANK2 EXPH5 C1orf43 MCAM ANKRD26 EPB41L5 ARFGEF1 PLEKHA6 FAT1 PHLDB1 PTPN14 EPB41L1 IL6ST | 1.52e-07 | 569 | 170 | 15 | 30639242 |
| Pubmed | ZBTB2 CTTNBP2 EXPH5 RNPC3 ANKRD26 EPB41L5 ZNF407 PLEKHA6 WDFY4 ALMS1 ARID2 CGNL1 TASOR CCSER1 | 1.64e-07 | 493 | 170 | 14 | 15368895 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MATR3 CRTC1 F5 CFAP20DC FAT1 PHLDB1 MICU3 PRRC2C ASXL3 SLC35D3 SRRM2 SPEN | 2.46e-07 | 361 | 170 | 12 | 26167880 |
| Pubmed | SAMSN1 SHROOM2 AKAP12 AXIN1 KMT2C ALMS1 PLEKHM2 STARD9 CEP295 SRRM2 | 2.50e-07 | 233 | 170 | 10 | 37704626 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 IRS4 RBBP4 CHAF1A MATR3 DDX42 ZDBF2 PAF1 BRD8 ZZZ3 BRCA1 PRRC2C ARID2 ATAD2B ZNF638 SRRM2 SPEN TASOR KNL1 | 2.50e-07 | 954 | 170 | 19 | 36373674 |
| Pubmed | IRS4 RBBP4 MATR3 PAF1 KMT2C BRD8 PTPN13 PTPN14 ZZZ3 ALMS1 PRRC2C ARID2 TACC3 SPEN | 5.95e-07 | 549 | 170 | 14 | 38280479 | |
| Pubmed | 7.36e-07 | 102 | 170 | 7 | 11214970 | ||
| Pubmed | 9.99e-07 | 339 | 170 | 11 | 30415952 | ||
| Pubmed | RANBP2 CHAF1A PLEKHA6 IWS1 KAT7 BRD8 EPC1 ZNF638 TACC3 BRAT1 SRRM2 SPEN EPB41L1 | 1.31e-06 | 503 | 170 | 13 | 16964243 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 FLI1 RANBP2 HDAC5 KMT2C ZZZ3 ALMS1 ASXL3 ARID2 EPC1 SPEN | 1.40e-06 | 351 | 170 | 11 | 38297188 |
| Pubmed | 1.81e-06 | 225 | 170 | 9 | 12168954 | ||
| Pubmed | RALGAPA1 USP34 TANK CHAF1A VPS4B DDX42 EPB41L5 ZDBF2 MTMR4 ALMS1 ZNF638 CEP295 PRR14L TASOR KNL1 | 3.54e-06 | 733 | 170 | 15 | 34672954 | |
| Pubmed | CHAF1A ANKRD26 XPC F5 IWS1 KAT7 C2CD3 BRD8 CCDC66 ALMS1 BRCA1 EPC1 ZNF638 SPEN | 3.89e-06 | 645 | 170 | 14 | 25281560 | |
| Pubmed | GPD2 RALGAPA1 RANBP2 IRS4 MCAM PAF1 IWS1 C2CD3 MTMR4 PTPN13 PTPN14 PTPRB SYNE2 ZNF638 CDC25A SRRM2 EPB41L1 KNL1 | 4.30e-06 | 1049 | 170 | 18 | 27880917 | |
| Pubmed | 4.54e-06 | 23 | 170 | 4 | 31281901 | ||
| Pubmed | CASP8AP2 RANBP2 MAP1A EXPH5 CHAF1A CRTC1 PLEKHA6 KMT2C ARID2 CGNL1 GOLGB1 GAREM1 | 5.40e-06 | 486 | 170 | 12 | 20936779 | |
| Pubmed | ASXL1 HDAC5 IFT172 PHLDB1 PLEKHM2 PRRC2C STARD9 KATNIP SRRM2 SPEN EPB41L1 | 5.77e-06 | 407 | 170 | 11 | 12693553 | |
| Pubmed | USP34 TMEM248 MATR3 DDX42 ASH1L CRTC1 SHROOM2 WDFY4 AKAP12 KAT7 KMT2C BRD8 PTPN13 ZNF638 CEP295 TASOR GOLGB1 ZNF445 | 6.73e-06 | 1084 | 170 | 18 | 11544199 | |
| Pubmed | RANBP2 CTTNBP2 ANK2 ANKRD26 ZNF407 CMYA5 PAF1 RNF11 AKAP12 ALMS1 SYNE2 IL6ST | 6.77e-06 | 497 | 170 | 12 | 23414517 | |
| Pubmed | IRS4 MCAM ANKRD26 EPB41L5 PLEKHA6 AKAP12 PHLDB1 PTPN13 PTPN14 EPB41L1 GOLGB1 | 7.93e-06 | 421 | 170 | 11 | 36976175 | |
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 19448621 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | FLI1 STAG1 RBBP4 CHAF1A XPC IWS1 KAT7 TRMT6 BRCA1 ARID2 ATAD2B ZBTB21 SPEN | 1.02e-05 | 608 | 170 | 13 | 36089195 |
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 1.03e-05 | 28 | 170 | 4 | 19661089 | |
| Pubmed | 1.08e-05 | 101 | 170 | 6 | 10997877 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.10e-05 | 153 | 170 | 7 | 26365490 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.27e-05 | 104 | 170 | 6 | 31240132 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 RANBP2 RBBP4 CHAF1A MATR3 DDX42 XPC PAF1 IWS1 KAT7 KMT2C BRD8 ZZZ3 BRCA1 EPC1 ZNF638 SRRM2 SPEN TASOR | 2.06e-05 | 1294 | 170 | 19 | 30804502 |
| Pubmed | RANBP2 CTTNBP2 ANK2 MATR3 PAF1 AKAP12 SIRPG STOX2 PRRC2C SYNE2 CNKSR3 ZBTB21 TACC3 BRSK1 EPB41L1 GOLGB1 | 2.23e-05 | 963 | 170 | 16 | 28671696 | |
| Pubmed | Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. | 2.38e-05 | 2 | 170 | 2 | 24218140 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23150505 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 2.38e-05 | 2 | 170 | 2 | 21164264 | |
| Pubmed | Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia. | 2.38e-05 | 2 | 170 | 2 | 26771811 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 8645611 | ||
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 2.38e-05 | 2 | 170 | 2 | 12231255 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20634641 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 1303253 | ||
| Pubmed | Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. | 2.38e-05 | 2 | 170 | 2 | 20334914 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 38757516 | ||
| Pubmed | Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells. | 2.38e-05 | 2 | 170 | 2 | 12354757 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 1741400 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26880370 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 32838755 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 32540969 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26047574 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 37098986 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26324851 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 7669222 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22933298 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 2783417 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 37288803 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 2.38e-05 | 2 | 170 | 2 | 2256920 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 2.38e-05 | 2 | 170 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 2.38e-05 | 2 | 170 | 2 | 16396990 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 2.38e-05 | 2 | 170 | 2 | 18397978 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 1518866 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23761669 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 2.38e-05 | 2 | 170 | 2 | 2592361 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23314847 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 2.38e-05 | 2 | 170 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 2.38e-05 | 2 | 170 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 2.38e-05 | 2 | 170 | 2 | 15731365 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 9188471 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 30454965 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15671307 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17651452 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 34638692 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 34743356 | ||
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 2.38e-05 | 2 | 170 | 2 | 20339375 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 35188604 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20808686 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17638892 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 2.38e-05 | 2 | 170 | 2 | 21519965 | |
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 2.38e-05 | 2 | 170 | 2 | 28653555 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 2.38e-05 | 2 | 170 | 2 | 21625068 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16110193 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26066897 | ||
| Pubmed | Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms. | 2.38e-05 | 2 | 170 | 2 | 23009937 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 8074693 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18651133 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25596262 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22083159 | ||
| Pubmed | Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. | 2.38e-05 | 2 | 170 | 2 | 26095772 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 9757574 | ||
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 2.38e-05 | 2 | 170 | 2 | 15699546 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18162527 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 38341019 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24837548 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 30046010 | ||
| Interaction | SFN interactions | RALGAPA1 TET2 IRS4 HDAC5 MAP1A MAP2 EXPH5 MATR3 ANKRD26 EPB41L5 IRS1 SAMSN1 KAT7 STOX2 PHLDB1 MTMR4 PTPN13 PTPN14 ALMS1 PRRC2C ZBTB21 ZNF638 CGNL1 CDC25A SRRM2 GPRIN2 CCSER1 | 1.47e-11 | 692 | 165 | 27 | int:SFN |
| Interaction | YWHAG interactions | RALGAPA1 TET2 IRS4 HDAC5 MAP2 EXPH5 CHAF1A MATR3 ANKRD26 EPB41L5 CRTC1 IRS1 SAMSN1 SHROOM2 STOX2 PHLDB1 C2CD3 MTMR4 PTPN13 PTPN14 DLC1 ALMS1 PRRC2C STARD9 SYNE2 CNKSR3 ZBTB21 ZNF638 CGNL1 CDC25A SRRM2 EPB41L1 GAREM1 CCSER1 | 4.38e-10 | 1248 | 165 | 34 | int:YWHAG |
| Interaction | YWHAH interactions | RALGAPA1 TET2 IRS4 HDAC5 MAP2 EXPH5 MATR3 ANKRD26 EPB41L5 CRTC1 IRS1 STIL SAMSN1 STOX2 PHLDB1 C2CD3 MTMR4 PTPN13 PTPN14 ALMS1 PRRC2C STARD9 SYNE2 CNKSR3 ZBTB21 ZNF638 CGNL1 CDC25A SRRM2 EPB41L1 CCSER1 | 1.38e-09 | 1102 | 165 | 31 | int:YWHAH |
| Interaction | YWHAZ interactions | RALGAPA1 TET2 ASXL1 IRS4 HDAC5 COL6A6 MAP2 EXPH5 CHAF1A MATR3 ANKRD26 CRTC1 IRS1 SAMSN1 STOX2 PHLDB1 MTMR4 PTPN13 PTPN14 BRCA1 STARD9 ASXL3 SYNE2 CNKSR3 ZBTB21 ZNF638 KATNIP PRR14L CGNL1 EXOC2 CDC25A EPB41L1 GAREM1 CCSER1 | 1.83e-09 | 1319 | 165 | 34 | int:YWHAZ |
| Interaction | YWHAQ interactions | RALGAPA1 TET2 ZBTB2 IRS4 HDAC5 MAP2 EXPH5 CHAF1A MATR3 ANKRD26 EPB41L5 CRTC1 IRS1 SAMSN1 RNF11 STOX2 PHLDB1 MTMR4 PTPN13 PTPN14 BRCA1 STARD9 CNKSR3 ZBTB21 ZNF638 CGNL1 CDC25A EPB41L1 GOLGB1 GAREM1 CCSER1 | 1.95e-09 | 1118 | 165 | 31 | int:YWHAQ |
| Interaction | NUP43 interactions | USP34 CASP8AP2 RANBP2 ASH1L ZDBF2 CCDC168 XPC PAF1 HELB IWS1 BRD8 ZZZ3 BRCA1 PRRC2C ARID2 ATAD2B SYNE2 EPC1 SRRM2 SPEN KNL1 | 4.43e-08 | 625 | 165 | 21 | int:NUP43 |
| Interaction | YWHAB interactions | RALGAPA1 TET2 IRS4 HDAC5 MAP2 EXPH5 CHAF1A MATR3 ANKRD26 EPB41L5 CRTC1 IRS1 SAMSN1 STOX2 PHLDB1 MTMR4 PTPN13 PTPN14 STARD9 CNKSR3 ZBTB21 ZNF638 CGNL1 CDC25A SRRM2 EPB41L1 CCSER1 | 5.77e-08 | 1014 | 165 | 27 | int:YWHAB |
| Interaction | YWHAE interactions | RALGAPA1 TET2 IRS4 HDAC5 RBBP4 EXPH5 CHAF1A MATR3 ANKRD26 CRTC1 IRS1 SAMSN1 SHROOM2 STOX2 PHLDB1 MTMR4 PTPN13 PTPN14 BRCA1 CNKSR3 ZBTB21 ZNF638 CGNL1 BRSK1 CDC25A SRRM2 EPB41L1 GPRIN2 GAREM1 CCSER1 | 1.05e-07 | 1256 | 165 | 30 | int:YWHAE |
| Interaction | HDAC1 interactions | TET2 CASP8AP2 RANBP2 ZBTB2 IRS4 HDAC5 STAG1 RBBP4 CHAF1A VPS4B MATR3 ARFGEF1 CRTC1 ZDBF2 SAMSN1 PTPN13 ZZZ3 ALMS1 BRCA1 SYNE2 ZBTB21 ZNF638 TACC3 SPEN TASOR GOLGB1 KNL1 | 3.41e-07 | 1108 | 165 | 27 | int:HDAC1 |
| Interaction | PHF21A interactions | USP34 CASP8AP2 RANBP2 IRS4 HDAC5 VPS4B CRTC1 ZDBF2 PTPN13 ZZZ3 ALMS1 TACC3 GOLGB1 KNL1 | 9.36e-07 | 343 | 165 | 14 | int:PHF21A |
| Interaction | RCOR1 interactions | USP34 CASP8AP2 RANBP2 IRS4 HDAC5 RBBP4 VPS4B MATR3 ZDBF2 PTPN13 ZZZ3 ALMS1 ZBTB21 SPEN TASOR KNL1 | 3.17e-06 | 494 | 165 | 16 | int:RCOR1 |
| Interaction | SSRP1 interactions | ASXL1 RANBP2 ZBTB2 RBBP4 CHAF1A MATR3 DDX42 EPB41L5 XPC PAF1 IWS1 KAT7 BRCA1 ZNF638 GINS2 SRRM2 TASOR | 4.89e-05 | 685 | 165 | 17 | int:SSRP1 |
| Interaction | NAA40 interactions | RANBP2 IRS4 ANK2 MAP1A MATR3 DDX42 ANKRD26 XPC PAF1 AKAP12 PTPN13 ALMS1 PRRC2C ARID2 ZBTB21 ZNF638 PRR14L CGNL1 TASOR GOLGB1 KNL1 | 5.13e-05 | 978 | 165 | 21 | int:NAA40 |
| Interaction | RNF43 interactions | RANBP2 IRS4 EXPH5 MATR3 ANKRD26 EPB41L5 AXIN1 STOX2 PTPN13 PTPN14 ALMS1 ZNF638 GOLGB1 | 5.22e-05 | 427 | 165 | 13 | int:RNF43 |
| Interaction | SYNE3 interactions | RANBP2 EXPH5 C1orf43 ANKRD26 STIL C2CD3 CCDC66 PTPN14 MIA2 ALMS1 SYNE2 CEP295 CGNL1 | 7.74e-05 | 444 | 165 | 13 | int:SYNE3 |
| Interaction | CEP135 interactions | TANK CHAF1A ANKRD26 STIL C2CD3 CCDC66 ALMS1 CEP295 CGNL1 GOLGB1 | 8.47e-05 | 272 | 165 | 10 | int:CEP135 |
| Interaction | KDM1A interactions | TET2 USP34 CASP8AP2 RANBP2 IRS4 HDAC5 RBBP4 CHAF1A VPS4B CRTC1 ZDBF2 PTPN13 ZZZ3 ALMS1 BRCA1 ZBTB21 TACC3 TASOR GOLGB1 KNL1 | 9.01e-05 | 941 | 165 | 20 | int:KDM1A |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.64e-05 | 29 | 109 | 4 | 396 | |
| GeneFamily | Cytochrome P450 family 11 | 1.08e-04 | 3 | 109 | 2 | 1007 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.14e-04 | 4 | 109 | 2 | 1244 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.33e-04 | 50 | 109 | 4 | 1293 | |
| GeneFamily | Transcription elongation factor A like family | 1.26e-03 | 9 | 109 | 2 | 1216 | |
| GeneFamily | Fibronectin type III domain containing | 2.84e-03 | 160 | 109 | 5 | 555 | |
| GeneFamily | AT-rich interaction domain containing | 3.59e-03 | 15 | 109 | 2 | 418 | |
| GeneFamily | StAR related lipid transfer domain containing | 3.59e-03 | 15 | 109 | 2 | 759 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 ASXL1 RANBP2 TANK STAG1 DDX42 ARFGEF1 IRS1 EXT1 STIL REV3L JARID2 FAT1 C2CD3 PTPN13 ZZZ3 DLC1 MIA2 BRCA1 PRRC2C ATAD2B SYNE2 ZNF638 AKAP10 OSMR SPEN TASOR | 7.82e-12 | 856 | 168 | 27 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 TCEAL3 CTTNBP2 ARFGEF1 ZNF407 EXT1 REV3L IWS1 STOX2 GTF2H2 PTPN13 ZZZ3 BRCA1 SYNE2 ZNF638 POLQ TASOR GOLGB1 KNL1 GAREM1 | 8.95e-09 | 656 | 168 | 20 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STAG1 ARFGEF1 IRS1 EXT1 STIL REV3L JARID2 FAT1 C2CD3 ZZZ3 DLC1 BRCA1 PRRC2C ATAD2B ZNF638 SPEN TASOR | 9.31e-09 | 466 | 168 | 17 | M13522 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 TET2 ASXL1 STIL IWS1 KAT7 KMT2C BRCA1 PRRC2C ATAD2B PRR14L | 2.50e-08 | 180 | 168 | 11 | M8239 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | ANK2 ASH1L ANKRD26 PLEKHA6 PRRC2C SYNE2 ZNF804B CNKSR3 CGNL1 SRRM2 GOLGB1 | 2.02e-07 | 221 | 168 | 11 | M39222 |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP | FLI1 CASP8AP2 MATR3 DDX42 ANKRD26 DENND1C PLEKHA6 AXIN1 MTMR4 POLQ | 6.74e-07 | 199 | 168 | 10 | M3262 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 2.04e-06 | 175 | 168 | 9 | M336 | |
| Coexpression | FISCHER_DREAM_TARGETS | GPD2 CASP8AP2 ASXL1 STAG1 RBBP4 RNPC3 CHAF1A STIL KAT7 BRD8 ALMS1 BRCA1 UBE2T ARID2 GINS2 CEP295 TACC3 CDC25A POLQ KNL1 | 4.32e-06 | 969 | 168 | 20 | M149 |
| Coexpression | BENPORATH_CYCLING_GENES | RAB23 CASP8AP2 ASXL1 PLK2 STAG1 RNPC3 CHAF1A MCAM STIL BRD8 BRCA1 UBE2T GINS2 TACC3 CDC25A POLQ | 4.62e-06 | 648 | 168 | 16 | M8156 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 5.59e-06 | 40 | 168 | 5 | MM17488 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 5.84e-06 | 199 | 168 | 9 | M6987 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN | 6.09e-06 | 200 | 168 | 9 | M8331 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 6.09e-06 | 200 | 168 | 9 | M5901 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CASP8AP2 CHAF1A ANKRD26 STIL ANKRD36C PAF1 SIRPG BRD8 ALMS1 BRCA1 UBE2T ARID2 SYNE2 GINS2 CEP295 TACC3 POLQ IL6ST KNL1 | 1.01e-05 | 939 | 168 | 19 | M45768 |
| Coexpression | CHICAS_RB1_TARGETS_SENESCENT | GPD2 CASP8AP2 TCEAL3 RBBP4 AKAP12 JARID2 UBE2T PRRC2C GINS2 OSMR CDC25A SRRM2 SPEN IL6ST | 1.79e-05 | 565 | 168 | 14 | M2125 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | CHAF1A IRS1 FREM1 GTF2H2 BRCA1 UBE2T SYNE2 GINS2 TACC3 CDC25A KNL1 | 1.91e-05 | 354 | 168 | 11 | M39061 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 2.04e-05 | 178 | 168 | 8 | M8996 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | GPD2 FLI1 ASXL1 ZBTB2 EXT1 SAMSN1 JARID2 GVINP1 SYNE2 EXOC2 CD96 IL6ST KNL1 | 2.10e-05 | 498 | 168 | 13 | M1741 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | USP34 CASP8AP2 ASXL1 CTTNBP2 MATR3 ANKRD26 TRMT6 GTF2H2 PTPN14 BRCA1 PRR14L CDC25A | 2.52e-05 | 434 | 168 | 12 | M15150 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | GPD2 FLI1 ASXL1 ZBTB2 EXT1 SAMSN1 JARID2 GVINP1 SYNE2 EXOC2 CD96 IL6ST KNL1 | 2.53e-05 | 507 | 168 | 13 | MM1030 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.54e-05 | 300 | 168 | 10 | M8702 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | RAB23 GPD2 FLI1 CASP8AP2 STAG1 RBBP4 NEXMIF CHAF1A MATR3 C1orf43 AKAP12 TRMT6 MTMR4 GTF2H2 BRCA1 UBE2T FBXO43 GINS2 TACC3 CDC25A POLQ KNL1 | 2.78e-05 | 1290 | 168 | 22 | M80 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | USP34 CASP8AP2 ASXL1 CTTNBP2 MATR3 ANKRD26 TRMT6 GTF2H2 PTPN14 BRCA1 PRR14L CDC25A | 3.43e-05 | 448 | 168 | 12 | MM1044 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | USP34 RANBP2 MAP1A MAP2 EXPH5 NEXMIF MATR3 C1orf43 ASH1L XPC PLEKHA6 ZC3H6 KMT2C ZZZ3 SYNE2 EXOC2 EPB41L1 GOLGB1 | 3.92e-05 | 946 | 168 | 18 | M39169 |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | CASP8AP2 TMEM248 MAP1A MAP2 STIL ZC3H6 DNAAF2 EPC1 ASPSCR1 SRRM2 | 3.95e-05 | 316 | 168 | 10 | M2248 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 4.31e-05 | 145 | 168 | 7 | M1810 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | CASP8AP2 TMEM248 MAP1A MAP2 STIL ZC3H6 DNAAF2 EPC1 ASPSCR1 SRRM2 | 4.39e-05 | 320 | 168 | 10 | MM1063 |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 4.50e-05 | 146 | 168 | 7 | M9372 | |
| Coexpression | KAUFFMANN_MELANOMA_RELAPSE_UP | 4.54e-05 | 61 | 168 | 5 | M2431 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 4.68e-05 | 200 | 168 | 8 | M8306 | |
| Coexpression | GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN | 4.68e-05 | 200 | 168 | 8 | M4398 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CASP8AP2 CHAF1A STIL CFAP20DC FAT1 BRCA1 GINS2 TACC3 CDC25A POLQ KNL1 | 6.06e-05 | 402 | 168 | 11 | MM454 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | RAB23 USP34 SLC39A9 RNPC3 MCAM ARFGEF1 ZNF215 STIL ZNF519 STOX2 BRCA1 CEP295 CGNL1 CDC25A POLQ IL6ST KNL1 | 6.37e-05 | 892 | 168 | 17 | M18120 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 7.05e-05 | 212 | 168 | 8 | M39221 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | GPD2 TANK SLC39A9 RBBP4 MATR3 C1orf43 STIL GTF2H2 PTPN14 BRCA1 GINS2 OSMR IL6ST KNL1 | 7.39e-05 | 644 | 168 | 14 | M10501 |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 8.35e-05 | 279 | 168 | 9 | M16867 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 9.03e-05 | 163 | 168 | 7 | M8235 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | 9.42e-05 | 221 | 168 | 8 | M45789 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.22e-04 | 171 | 168 | 7 | M39234 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | GPD2 FLI1 CTTNBP2 RNPC3 ASH1L ZNF300 IRS1 SHROOM2 RNF11 JARID2 KMT2C PTPRB GVINP1 OSMR TASOR IL6ST | 1.28e-04 | 854 | 168 | 16 | M1533 |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 1.76e-04 | 242 | 168 | 8 | M12816 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP | CCDC168 STIL CEACAM1 PTPN14 BRS3 MYO3B CNKSR3 CGNL1 CD96 KNL1 | 1.96e-04 | 384 | 168 | 10 | M798 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | GPD2 FLI1 CTTNBP2 RNPC3 ASH1L ZNF300 IRS1 SHROOM2 RNF11 SIRPG JARID2 KMT2C PTPRB OSMR TASOR IL6ST | 2.00e-04 | 888 | 168 | 16 | MM1018 |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 2.19e-04 | 250 | 168 | 8 | M39170 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G1_S | 2.22e-04 | 133 | 168 | 6 | M2074 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 USP34 FLI1 RANBP2 TANK MATR3 ASH1L DENND1C REV3L SAMSN1 ZC3H6 SIRPG JARID2 KMT2C GVINP1 ARID2 EPC1 ZNF638 AKAP10 SPEN TASOR CD96 | 2.30e-04 | 1492 | 168 | 22 | M40023 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 2.50e-04 | 323 | 168 | 9 | M2156 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 2.73e-04 | 195 | 168 | 7 | M13736 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 2.99e-04 | 198 | 168 | 7 | M8036 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 2.99e-04 | 198 | 168 | 7 | M9346 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 2.99e-04 | 198 | 168 | 7 | M7200 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 3.09e-04 | 199 | 168 | 7 | M3257 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN | 3.09e-04 | 199 | 168 | 7 | M9832 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | USP34 TCEAL3 MAP2 RBBP4 PKDREJ CEACAM1 SIRPG KAT7 PTPN13 PTPN14 TCEAL6 BRAT1 IL6ST ZNF445 | 3.15e-04 | 741 | 168 | 14 | MM1037 |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 3.18e-04 | 200 | 168 | 7 | M4622 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 3.18e-04 | 200 | 168 | 7 | M9354 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP | 3.18e-04 | 200 | 168 | 7 | M5119 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 3.18e-04 | 200 | 168 | 7 | M3020 | |
| Coexpression | SAGIV_CD24_TARGETS_UP | 3.64e-04 | 22 | 168 | 3 | M4144 | |
| Coexpression | CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL | 3.67e-04 | 146 | 168 | 6 | M39301 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | ASXL1 XPC PLEKHA6 ADGRV1 ZC3H6 PRRC2C ZNF804B ASPSCR1 SRRM2 GOLGB1 | 3.77e-04 | 417 | 168 | 10 | M39224 |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 3.80e-04 | 206 | 168 | 7 | M39254 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CASP8AP2 SYCP2L IRS4 MAP1A MAP2 ANKRD26 EPB41L5 ZDBF2 ADGRV1 IWS1 STOX2 ALMS1 BRCA1 SYNE2 CEP295 POLQ KNL1 | 4.35e-07 | 498 | 167 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CASP8AP2 SYCP2L RANBP2 IRS4 MAP1A MAP2 ANKRD26 EPB41L5 ZDBF2 ADGRV1 REV3L IWS1 STOX2 TRMT6 CCDC66 ALMS1 BRCA1 COG1 PLEKHM2 ATAD2B SYNE2 CEP295 POLQ KNL1 | 8.97e-07 | 989 | 167 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CASP8AP2 RANBP2 ANKRD26 REV3L IWS1 CCDC66 ALMS1 BRCA1 ATAD2B SYNE2 CEP295 POLQ KNL1 | 1.16e-06 | 311 | 167 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CASP8AP2 SYCP2L RANBP2 ANK2 MAP1A MAP2 CHAF1A ANKRD26 EPB41L5 ZDBF2 ADGRV1 RNF11 IWS1 DNAAF2 STOX2 CCDC66 ALMS1 BRCA1 ATAD2B SYNE2 KATNIP POLQ CCSER1 | 2.86e-06 | 983 | 167 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | CASP8AP2 ANKRD26 ZDBF2 IWS1 ALMS1 BRCA1 SYNE2 CEP295 POLQ KNL1 | 2.99e-06 | 192 | 167 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 RANBP2 ANKRD26 EPB41L5 ZDBF2 STIL IWS1 DNAAF2 GTF2H2 BRD8 MIA2 ALMS1 BRCA1 PRRC2C ZNF638 POLQ | 4.94e-06 | 532 | 167 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | RAB23 TET2 FLI1 CASP8AP2 COL6A6 MAP2 RNPC3 ANKRD26 STIL REV3L SAMSN1 ZNF519 FREM1 JARID2 TRMT6 CCDC66 MIA2 ALMS1 UBE2T GVINP1 ATAD2B SYNE2 ZNF638 CEP295 KNL1 NAA16 | 5.34e-06 | 1252 | 167 | 26 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | GPD2 CASP8AP2 ANK2 MAP1A MAP2 CHAF1A ANKRD26 EPB41L5 ZDBF2 ADGRV1 STIL REV3L SAMSN1 SHROOM2 JARID2 STOX2 FAT1 GTF2H2 CCDC66 ALMS1 BRCA1 PLEKHM2 SYNE2 CEP295 MAPK4 KNL1 GAREM1 | 8.97e-06 | 1370 | 167 | 27 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | CASS4 CHAF1A XPC STIL WDFY4 CEACAM1 BRCA1 HP SYNE2 TACC3 CDC25A POLQ KNL1 | 1.28e-05 | 388 | 167 | 13 | GSM538352_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | RBBP4 VPS4B DDX42 ASH1L KAT7 PRRC2C STARD9 SYNE2 CEP295 GAREM1 ZNF445 | 1.61e-05 | 284 | 167 | 11 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | CASP8AP2 SYCP2L RANBP2 MAP1A MAP2 CHAF1A EPB41L5 ZDBF2 ADGRV1 IWS1 CCDC66 BRCA1 SYNE2 CCSER1 | 3.71e-05 | 493 | 167 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | MAP2 MUC16 IRS1 EXT1 ZDBF2 FREM1 STOX2 HMCN1 ASXL3 GINS2 TCEAL6 | 3.71e-05 | 311 | 167 | 11 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | MAP1A MAP2 MUC16 IRS1 EXT1 ZDBF2 FREM1 HMCN1 ASXL3 GINS2 TCEAL6 | 5.84e-05 | 327 | 167 | 11 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | CASP8AP2 TCEAL3 ANKRD26 ZDBF2 CCDC66 ALMS1 PLEKHM2 ATAD2B EPB41L1 KNL1 | 5.92e-05 | 271 | 167 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CASP8AP2 SYCP2L ANK2 MAP2 RNPC3 ANKRD26 ZDBF2 ADGRV1 STIL REV3L ZNF519 IWS1 JARID2 TRMT6 GTF2H2 CCDC66 ALMS1 BRCA1 UBE2T ATAD2B SYNE2 CEP295 MAPK4 KNL1 NAA16 CCSER1 | 7.39e-05 | 1459 | 167 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZBTB2 MATR3 EPB41L5 ARFGEF1 ZNF407 ZDBF2 PAF1 CFAP20DC COG1 ATAD2B SYNE2 CEP295 TASOR GOLGB1 ZNF445 | 7.52e-05 | 595 | 167 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | RAB23 CASP8AP2 ANK2 MAP1A RNPC3 NEXMIF ANKRD26 EPB41L5 EXT1 ZDBF2 DENND1C STIL STOX2 CCDC66 ALMS1 BRCA1 ATAD2B SYNE2 CEP295 MAPK4 KNL1 | 9.17e-05 | 1060 | 167 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RALGAPA1 CASP8AP2 RANBP2 ASH1L ANKRD26 EPB41L5 ZDBF2 IWS1 CCDC66 ALMS1 BRCA1 COG1 SYNE2 EPC1 CEP295 PRR14L POLQ KNL1 | 1.00e-04 | 831 | 167 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.15e-04 | 186 | 167 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | RAB23 CASP8AP2 SYCP2L ANK2 MAP1A MAP2 RNPC3 NEXMIF ANKRD26 EPB41L5 EXT1 ZDBF2 DENND1C PLEKHA6 ADGRV1 STIL STOX2 CCDC66 ALMS1 BRCA1 ATAD2B SYNE2 CEP295 MAPK4 KNL1 | 1.17e-04 | 1414 | 167 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.23e-04 | 240 | 167 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | FLI1 CASP8AP2 SYCP2L TCEAL3 ANKRD26 ZDBF2 CCDC66 ALMS1 PLEKHM2 ASXL3 ATAD2B ZNF638 KNL1 | 1.45e-04 | 492 | 167 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.79e-04 | 310 | 167 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.84e-04 | 199 | 167 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | PLK2 MAP1A MAP2 NEXMIF MUC16 IRS1 EXT1 PALMD SH3D21 FREM1 PTPN13 DLC1 HMCN1 ASXL3 GINS2 TCEAL6 EPB41L1 | 1.89e-04 | 797 | 167 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | CTTNBP2 RBBP4 ASH1L ANKRD26 RNF11 BRD8 PRRC2C SYNE2 CEP295 ZNF445 | 2.49e-04 | 323 | 167 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | FLI1 SYCP2L MAP2 RNPC3 ARFGEF1 REV3L SAMSN1 IWS1 TRMT6 MTMR4 CCDC66 UBE2T COG1 ATAD2B SYNE2 CEP295 TACC3 GOLGB1 KNL1 | 2.98e-04 | 989 | 167 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_500 | 3.14e-04 | 116 | 167 | 6 | gudmap_kidney_adult_RenCorpuscGlomer_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K0 | 3.27e-04 | 42 | 167 | 4 | facebase_RNAseq_e9.5_OlfPlac_2500_K0 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.37e-04 | 165 | 167 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.48e-04 | 337 | 167 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 ANK2 RNPC3 ANKRD26 ZDBF2 STIL REV3L ZNF519 IWS1 JARID2 TRMT6 GTF2H2 CCDC66 ALMS1 BRCA1 UBE2T ATAD2B SYNE2 CEP295 KNL1 NAA16 CCSER1 | 3.58e-04 | 1257 | 167 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.97e-04 | 281 | 167 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TET2 MAP1A MAP2 NEXMIF MUC16 IRS1 PALMD REV3L FREM1 STOX2 DLC1 HMCN1 ASXL3 GINS2 TCEAL6 KNL1 | 4.32e-04 | 777 | 167 | 16 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZBTB2 ZNF407 IWS1 CFAP20DC CCDC66 ZZZ3 COG1 ATAD2B SYNE2 CEP295 EPB41L1 GOLGB1 KNL1 ZNF445 | 4.66e-04 | 629 | 167 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Endothelial_2500_K0 | 4.89e-04 | 126 | 167 | 6 | gudmap_RNAseq_e15.5_Endothelial_2500_K0 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 5.14e-04 | 232 | 167 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | GPD2 MAP1A MAP2 NEXMIF MUC16 IRS1 EXT1 ZDBF2 PALMD FREM1 PTPN13 HMCN1 ASXL3 GINS2 TCEAL6 EPB41L1 | 5.69e-04 | 797 | 167 | 16 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#1_top-relative-expression-ranked_100 | 6.59e-04 | 22 | 167 | 3 | gudmap_kidney_adult_GlomCapSys_Tie2_k1_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.68e-04 | 185 | 167 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 RANBP2 TCEAL3 ANKRD26 EPB41L5 ZDBF2 IWS1 DNAAF2 CCDC66 ALMS1 BRCA1 STARD9 SYNE2 POLQ | 6.82e-04 | 654 | 167 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | FLI1 CASP8AP2 SYCP2L TCEAL3 NEXMIF ANKRD26 ZDBF2 STIL SH3D21 CCDC66 ALMS1 PLEKHM2 ASXL3 ATAD2B ZNF638 EPB41L1 KNL1 CCSER1 | 7.13e-04 | 978 | 167 | 18 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | SYCP2L MAP1A MAP2 EPB41L5 ARFGEF1 ZNF407 ZDBF2 ADGRV1 CFAP20DC STOX2 MTMR4 UBE2T COG1 ATAD2B SYNE2 TACC3 GOLGB1 CCSER1 | 7.22e-04 | 979 | 167 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 7.32e-04 | 136 | 167 | 6 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.16e-04 | 249 | 167 | 8 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FLI1 CASP8AP2 MAP1A CHAF1A MUC16 IRS1 EXT1 ZDBF2 REV3L FREM1 PTPN13 HMCN1 ASXL3 SYNE2 GINS2 TCEAL6 | 8.43e-04 | 827 | 167 | 16 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_200 | 8.56e-04 | 24 | 167 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k2_200 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RALGAPA1 USP34 RANBP2 ASH1L ARFGEF1 ZNF407 ANKRD36C KMT2C ARID2 SYNE2 SPEN IL6ST GOLGB1 | 4.05e-13 | 188 | 169 | 13 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CASP8AP2 RANBP2 STAG1 ASH1L PALMD CEACAM1 PTPRB GVINP1 PRRC2C SYNE2 SRRM2 TASOR | 4.48e-12 | 178 | 169 | 12 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RALGAPA1 USP34 RNPC3 ASH1L ARFGEF1 ZNF407 ANKRD36C HELB PRRC2C ATAD2B SYNE2 GOLGB1 | 1.66e-11 | 199 | 169 | 12 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | FLI1 EXT1 SHROOM2 AKAP12 PTPRB HMCN1 ZNF804B CGNL1 OSMR IL6ST | 3.02e-09 | 189 | 169 | 10 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CHAF1A STIL ANKRD36C PTPRB BRCA1 STARD9 FBXO43 TACC3 POLQ KNL1 | 3.18e-09 | 190 | 169 | 10 | 31de1727822e9818652946dfb962daee77ffad68 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CHAF1A STIL REV3L CFAP20DC ALMS1 BRCA1 UBE2T ZBTB21 CEP295 KNL1 | 3.88e-09 | 194 | 169 | 10 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPD2 COL6A6 ASH1L ARFGEF1 REV3L KMT2C SLC24A2 PRRC2C SRRM2 GOLGB1 | 4.08e-09 | 195 | 169 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPD2 COL6A6 ASH1L ARFGEF1 REV3L KMT2C SLC24A2 PRRC2C SRRM2 GOLGB1 | 4.08e-09 | 195 | 169 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.20e-09 | 200 | 169 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.20e-09 | 200 | 169 | 10 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.20e-09 | 200 | 169 | 10 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 5.20e-09 | 200 | 169 | 10 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-08 | 167 | 169 | 9 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | RALGAPA1 RANBP2 ZNF407 ANKRD36C HELB PRRC2C SYNE2 IL6ST GOLGB1 | 1.99e-08 | 171 | 169 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 177 | 169 | 9 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.81e-08 | 178 | 169 | 9 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-08 | 179 | 169 | 9 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-08 | 180 | 169 | 9 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.25e-08 | 181 | 169 | 9 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.11e-08 | 186 | 169 | 9 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.93e-08 | 190 | 169 | 9 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | RALGAPA1 RANBP2 ASH1L ARFGEF1 ANKRD36C HELB KMT2C SYNE2 IL6ST | 5.39e-08 | 192 | 169 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.39e-08 | 192 | 169 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.39e-08 | 192 | 169 | 9 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.64e-08 | 193 | 169 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | EPB41L5 PLEKHA6 CMYA5 FAT1 PTPN13 CGNL1 EPB41L1 GAREM1 CCSER1 | 5.64e-08 | 193 | 169 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.89e-08 | 194 | 169 | 9 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.89e-08 | 194 | 169 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 5.89e-08 | 194 | 169 | 9 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.89e-08 | 194 | 169 | 9 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.89e-08 | 194 | 169 | 9 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.89e-08 | 194 | 169 | 9 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.16e-08 | 195 | 169 | 9 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.16e-08 | 195 | 169 | 9 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.16e-08 | 195 | 169 | 9 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.44e-08 | 196 | 169 | 9 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.44e-08 | 196 | 169 | 9 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.44e-08 | 196 | 169 | 9 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.44e-08 | 196 | 169 | 9 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.44e-08 | 196 | 169 | 9 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.44e-08 | 196 | 169 | 9 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 6.44e-08 | 196 | 169 | 9 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.72e-08 | 197 | 169 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 6.72e-08 | 197 | 169 | 9 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 6.72e-08 | 197 | 169 | 9 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 7.02e-08 | 198 | 169 | 9 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 7.02e-08 | 198 | 169 | 9 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.33e-08 | 199 | 169 | 9 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-08 | 199 | 169 | 9 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 7.33e-08 | 199 | 169 | 9 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.33e-08 | 199 | 169 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.65e-08 | 200 | 169 | 9 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | Severe-Lymphoid-T-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 7.65e-08 | 200 | 169 | 9 | 266270c756fb69945449ce02da04743cd31f8158 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.65e-08 | 200 | 169 | 9 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.65e-08 | 200 | 169 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-08 | 200 | 169 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.65e-08 | 200 | 169 | 9 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 1.59e-07 | 157 | 169 | 8 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.03e-07 | 162 | 169 | 8 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-07 | 167 | 169 | 8 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-07 | 168 | 169 | 8 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 169 | 169 | 8 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 169 | 169 | 8 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 173 | 169 | 8 | 20a20429aa898097d5ec4880ed64846558b5890f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-07 | 175 | 169 | 8 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-07 | 175 | 169 | 8 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-07 | 175 | 169 | 8 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 3.82e-07 | 176 | 169 | 8 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-07 | 176 | 169 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.72e-07 | 181 | 169 | 8 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.72e-07 | 181 | 169 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.13e-07 | 183 | 169 | 8 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-07 | 184 | 169 | 8 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-07 | 185 | 169 | 8 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-07 | 185 | 169 | 8 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-07 | 186 | 169 | 8 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-07 | 186 | 169 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.29e-07 | 188 | 169 | 8 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.29e-07 | 188 | 169 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 6.55e-07 | 189 | 169 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.82e-07 | 190 | 169 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.82e-07 | 190 | 169 | 8 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.82e-07 | 190 | 169 | 8 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.82e-07 | 190 | 169 | 8 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.82e-07 | 190 | 169 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 7.09e-07 | 191 | 169 | 8 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.09e-07 | 191 | 169 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.38e-07 | 192 | 169 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.38e-07 | 192 | 169 | 8 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.67e-07 | 193 | 169 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.67e-07 | 193 | 169 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.98e-07 | 194 | 169 | 8 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.98e-07 | 194 | 169 | 8 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 7.98e-07 | 194 | 169 | 8 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.98e-07 | 194 | 169 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 7.98e-07 | 194 | 169 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.98e-07 | 194 | 169 | 8 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-07 | 194 | 169 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.51e-07 | 50 | 100 | 7 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.36e-06 | 50 | 100 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.80e-06 | 45 | 162 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | melanoma | 6.45e-06 | 126 | 162 | 7 | EFO_0000756 | |
| Disease | apolipoprotein L1 measurement | 1.01e-05 | 25 | 162 | 4 | EFO_0021854 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.55e-05 | 63 | 162 | 5 | DOID:0050866 (is_marker_for) | |
| Disease | Glucocorticoid-remediable aldosteronism | 3.00e-05 | 2 | 162 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 3.00e-05 | 2 | 162 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TET2 IRS4 ANK2 MAP2 ARFGEF1 F5 AKAP12 KMT2C FAT1 ZZZ3 DLC1 NPAP1 IL6ST | 1.42e-04 | 702 | 162 | 13 | C0009402 |
| Disease | Neurodevelopmental Disorders | 1.65e-04 | 93 | 162 | 5 | C1535926 | |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 1.78e-04 | 4 | 162 | 2 | C1301365 | |
| Disease | level of izumo sperm-egg fusion protein 4 in blood serum | 1.78e-04 | 4 | 162 | 2 | OBA_2044625 | |
| Disease | level of haptoglobin in blood serum | 1.78e-04 | 4 | 162 | 2 | OBA_2041919 | |
| Disease | Myelodysplastic syndrome | 2.96e-04 | 5 | 162 | 2 | cv:C3463824 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 2.96e-04 | 5 | 162 | 2 | DOID:446 (is_implicated_in) | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.96e-04 | 5 | 162 | 2 | 614286 | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 2.96e-04 | 5 | 162 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | neuroticism measurement, cognitive function measurement | TET2 ASXL1 CTTNBP2 TANK STAG1 EXT1 SH3D21 ZZZ3 ASXL3 ZNF638 AKAP10 | 3.10e-04 | 566 | 162 | 11 | EFO_0007660, EFO_0008354 |
| Disease | pre-eclampsia (is_implicated_in) | 3.42e-04 | 25 | 162 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | cutaneous melanoma, hair color | 3.81e-04 | 62 | 162 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | serum dimethylarginine measurement | 4.05e-04 | 63 | 162 | 4 | EFO_0005418 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 4.31e-04 | 27 | 162 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Conn Syndrome | 4.43e-04 | 6 | 162 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 4.43e-04 | 6 | 162 | 2 | C0020428 | |
| Disease | age-related hearing impairment | 4.44e-04 | 324 | 162 | 8 | EFO_0005782 | |
| Disease | Polydactyly | 4.79e-04 | 117 | 162 | 5 | C0152427 | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.13e-04 | 67 | 162 | 4 | C3463824 | |
| Disease | colorectal cancer (is_implicated_in) | 5.58e-04 | 121 | 162 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | growth differentiation factor 15 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0009181 | |
| Disease | protocadherin alpha-7 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0801973 | |
| Disease | heparin cofactor 2 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0008150 | |
| Disease | testosterone measurement | TET2 ATP8B3 HORMAD2 SPEM3 ANK2 MAP1A STAG1 CYP11B1 CYP11B2 ZNF519 PKDREJ HMCN1 SYNE2 CNKSR3 USH2A MUCL3 KNL1 | 6.74e-04 | 1275 | 162 | 17 | EFO_0004908 |
| Disease | pentachlorophenol measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 7.47e-04 | 74 | 162 | 4 | EFO_0007886 | |
| Disease | intellectual disability (implicated_via_orthology) | 7.86e-04 | 75 | 162 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | sarcoma (is_implicated_in) | 8.21e-04 | 8 | 162 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.53e-04 | 447 | 162 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | colon cancer (is_implicated_in) | 1.02e-03 | 36 | 162 | 3 | DOID:219 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.04e-03 | 139 | 162 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.05e-03 | 9 | 162 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | protein FAM163B measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0802936 | |
| Disease | FEV/FEC ratio | TET2 USP34 ASXL1 CTTNBP2 MAP2 EPB41L5 CRTC1 SH3D21 KAT7 MICU3 DLC1 HMCN1 SYNE2 EPC1 ASPSCR1 EXOC2 | 1.23e-03 | 1228 | 162 | 16 | EFO_0004713 |
| Disease | androstenedione measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0007972 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0021862 | |
| Disease | nevus count, cutaneous melanoma | 1.61e-03 | 91 | 162 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | ejection fraction measurement | 1.71e-03 | 43 | 162 | 3 | EFO_0005527 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.91e-03 | 12 | 162 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Mouth Diseases | 1.91e-03 | 12 | 162 | 2 | C0026636 | |
| Disease | Gastrointestinal Stromal Sarcoma | 2.21e-03 | 47 | 162 | 3 | C3179349 | |
| Disease | Salivary Gland Neoplasms | 2.21e-03 | 47 | 162 | 3 | C0036095 | |
| Disease | Prostatic Neoplasms | 2.23e-03 | 616 | 162 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.23e-03 | 616 | 162 | 10 | C0376358 | |
| Disease | Bardet-Biedl Syndrome | 2.25e-03 | 13 | 162 | 2 | C0752166 | |
| Disease | Adenoid Cystic Carcinoma | 2.28e-03 | 100 | 162 | 4 | C0010606 | |
| Disease | retinal vasculature measurement | 2.31e-03 | 517 | 162 | 9 | EFO_0010554 | |
| Disease | neurotic disorder | 2.36e-03 | 101 | 162 | 4 | EFO_0004257 | |
| Disease | blood cobalt measurement | 2.36e-03 | 101 | 162 | 4 | EFO_0007577 | |
| Disease | platelet crit | CASS4 TET2 FLI1 MAP1A STAG1 EXPH5 MCAM EPB41L5 ZNF407 PLEKHA6 ADGRV1 SH3D21 SIRPG | 2.37e-03 | 952 | 162 | 13 | EFO_0007985 |
| Disease | Saldino-Noonan Syndrome | 2.61e-03 | 14 | 162 | 2 | C0036069 | |
| Disease | Gastrointestinal Stromal Tumors | 2.64e-03 | 50 | 162 | 3 | C0238198 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 2.82e-03 | 106 | 162 | 4 | EFO_0803333 | |
| Disease | idiopathic osteonecrosis of the femoral head | 2.95e-03 | 52 | 162 | 3 | EFO_1001930 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.00e-03 | 15 | 162 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 3.00e-03 | 15 | 162 | 2 | cv:C3711387 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 3.00e-03 | 15 | 162 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | calcium/calmodulin-dependent protein kinase type 1 measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0008062 | |
| Disease | endometrial carcinoma | 3.54e-03 | 113 | 162 | 4 | EFO_1001512 | |
| Disease | complement factor H-related protein 1 measurement | 3.64e-03 | 56 | 162 | 3 | EFO_0600054 | |
| Disease | hematocrit | RALGAPA1 CHAF1A ASH1L EPB41L5 CRTC1 PLEKHA6 ADGRV1 AGBL3 FAT1 ARID2 CGNL1 OSMR TASOR | 3.94e-03 | 1011 | 162 | 13 | EFO_0004348 |
| Disease | mean platelet volume | TET2 HDAC5 COL6A6 CRTC1 IRS1 STIL SIRPG BRD8 ATAD2B SYNE2 EPC1 AKAP10 TASOR | 4.25e-03 | 1020 | 162 | 13 | EFO_0004584 |
| Disease | blood nickel measurement | 4.39e-03 | 120 | 162 | 4 | EFO_0007583 | |
| Disease | balding measurement | TET2 CRTC1 REV3L AKAP12 AXIN1 PTPN14 DLC1 MYO3B EPC1 EXOC2 TACC3 | 4.47e-03 | 792 | 162 | 11 | EFO_0007825 |
| Disease | atrial fibrillation | 4.54e-03 | 371 | 162 | 7 | EFO_0000275 | |
| Disease | blood metabolite measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0005664 | |
| Disease | Adenocarcinoma of prostate | 5.33e-03 | 20 | 162 | 2 | C0007112 | |
| Disease | alpha-tocopherol measurement | 5.33e-03 | 20 | 162 | 2 | EFO_0007898 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQTRISESQHSLKPN | 1056 | Q68DN1 | |
| SSVDSVPRENHESEK | 806 | Q9H2F5 | |
| STLAESSDHVEKSPQ | 786 | Q6PJG6 | |
| SSDHVEKSPQSLLQD | 791 | Q6PJG6 | |
| HTQSNSDVKDTRPNE | 671 | Q8NEM8 | |
| TESPSKLESESDNHR | 916 | Q9NR48 | |
| EHTQEKQSTRAPAAA | 226 | Q9BZE9 | |
| TPSTKQREDEHSSEL | 626 | Q9NQ75 | |
| SKLTDLSQDDPVQDH | 1091 | Q9H0E9 | |
| AHSLNTVKQSSLAEP | 171 | O43572 | |
| ASEKLTASEQAHPQE | 346 | Q02952 | |
| VHSESDKAITPQAQE | 1751 | Q02952 | |
| SQKSVDIHDSIQPRS | 1566 | Q9Y6D6 | |
| HPESKETQQSSSENS | 271 | Q7Z2Y8 | |
| THEERNEEKPSLNSV | 3326 | Q8WXG9 | |
| LPSSHLTEEAKNVSA | 1301 | Q8TCU4 | |
| PNHTVKRVEDSSSNG | 576 | Q68CP9 | |
| AQHKASELETPASAQ | 281 | Q96PS8 | |
| QDVPAKARSTSLNDH | 471 | O60423 | |
| PKDQVATARQHSTFT | 846 | Q9C0I3 | |
| SHQAEPETSSKNSEE | 271 | Q9ULG3 | |
| IPKHSSQNSNSVDES | 226 | Q9UPS8 | |
| VDHNKLNSEASPSRE | 131 | Q13111 | |
| SHKAAEDSTAQENPT | 686 | Q8IV53 | |
| SIEDAQTSQHATLKP | 1271 | Q9UKL3 | |
| QTSQHATLKPERSFE | 1276 | Q9UKL3 | |
| QSFRNTIESVHTEKP | 546 | Q8IXJ9 | |
| HSSDENIPVSHLSEK | 1201 | Q9C0F0 | |
| TIEESIQHNSSFKPE | 706 | Q06278 | |
| SNQAVRIVKEPTSHD | 1316 | P49792 | |
| QIAEDPELTHSSSNK | 176 | Q9ULC3 | |
| VVENLDKPSSSELHS | 471 | Q99650 | |
| TASLQKVENDTSPHR | 56 | Q9BQ51 | |
| PASDSETEDASRHKQ | 311 | Q96ST2 | |
| SLEASPVLEDNSSHK | 2436 | Q01484 | |
| KHEELSINSNPVSSQ | 256 | Q5JPF3 | |
| VIDTNDHRPQFSTSK | 1446 | Q14517 | |
| DTEKTHPSSNRTVTD | 8046 | Q8WXI7 | |
| PRETIFGKSEHQNSS | 371 | Q9NP74 | |
| EANSNEKHPSQQDTR | 41 | Q9H4G0 | |
| EKHPSQQDTRPAEQS | 46 | Q9H4G0 | |
| SAFRHSQKVDSQTIP | 941 | P23467 | |
| DISSPNVSHDESIAK | 141 | O95251 | |
| TDPKSADTQSISRNH | 406 | P43304 | |
| EQQKSHPSESLDTDS | 586 | Q8NEZ4 | |
| EASKSHATTEPEQTE | 1936 | P78559 | |
| TNEEVAKNTHCSSLP | 811 | P43243 | |
| RDPAQIVQDKTSVSH | 1356 | Q5T1H1 | |
| LNHSENATAKDIAPT | 206 | P00738 | |
| SNNAVIELAKSPESH | 591 | Q9NVR5 | |
| EDVQVDPRKDSHSSS | 391 | P31152 | |
| SKETVFPSQITNEHE | 16 | Q8N7B1 | |
| PQRATTKVHSDDSDI | 826 | O60303 | |
| SEQINPHSTGARKTE | 1091 | Q9ULI0 | |
| GQKSPIIIHDDNSSD | 4891 | Q2LD37 | |
| SPTRQQFHSKPVDSD | 96 | Q86XP3 | |
| EQLSTKPDADIDTTH | 671 | Q96KP1 | |
| SKSVSNHSNLPDIVS | 716 | Q6N069 | |
| HNISVTKTDTNPSES | 576 | Q9H706 | |
| KVESTTDSHFPRQDQ | 1991 | Q5H8C1 | |
| HVKSSELVSQQDSSP | 591 | Q8NEV8 | |
| QDSSPVEVHINKEAS | 601 | Q8NEV8 | |
| REPSTHVSNQKSNSI | 1681 | Q8NEV8 | |
| DINHLETQPVSSKDS | 1706 | Q8NG31 | |
| HSPTNSVLKTDAEEL | 291 | Q86XE3 | |
| HQKTPSQSSVASIEE | 536 | P35568 | |
| VASISHQEQLSSVPD | 841 | Q9NYA4 | |
| DTRSNNTSKPSHSVD | 256 | Q09028 | |
| PSIKDHDSESLSVVN | 3056 | Q96RW7 | |
| NLVKSSEANSPAHEE | 1516 | Q9UG01 | |
| QIVHPDSEKRAAAAS | 401 | Q4G163 | |
| EIQAPTSSKRSQQHA | 111 | Q8N7H5 | |
| KVAESAQSPAAAHTT | 1606 | P38398 | |
| SHSQEPRENKNDTAL | 226 | B2RXH4 | |
| ATKPEELSVHNNVST | 386 | Q9HCM4 | |
| PDISHFERSKQVSSV | 826 | P40189 | |
| HQSAAKDLTQSPEVS | 201 | Q9BWL3 | |
| SSEFQPQIRTVAKSH | 286 | Q4AC94 | |
| ELESSTSNSPSNKHI | 451 | Q8WTW3 | |
| LENEDSSVHISPRQK | 71 | Q16394 | |
| LHSSNGSVPKENSEE | 86 | Q0VF96 | |
| SDQRDLTEHKPSVSN | 461 | P13688 | |
| SADQENTTALIPATH | 226 | Q6UUV9 | |
| QKEVSPLSSHQTTEC | 1581 | Q8WZ74 | |
| HSTARPKEQVEAEAT | 541 | O15169 | |
| NANHDETSSLLPRKE | 1711 | O75417 | |
| PDSQEATAHVSQDQK | 1211 | Q8N3K9 | |
| SHTDQSSRLSVKEDP | 206 | Q01543 | |
| SSVPAENKSVLNEHQ | 211 | A2RUB6 | |
| AAAASISEHPQKATT | 346 | P15538 | |
| THDQPSVQALADEKN | 716 | Q8TDC3 | |
| AAAASISEHPQKATT | 346 | P19099 | |
| STQVKQDTSPHEDSI | 1786 | Q8NDH2 | |
| AHQQETSSKVSPELA | 5761 | Q8NDH2 | |
| HLTASPKLSTQQEAE | 386 | Q9UQL6 | |
| EEETTTSEPSHKNIQ | 111 | Q9NQ60 | |
| AHSSSAQAEPKAAEQ | 206 | O60269 | |
| EEEKISAAQPQHTRS | 121 | A0A1B0GTK4 | |
| VQHSVASQASAKAEP | 1106 | Q9C0D2 | |
| QNSSDVHKSLLPAVD | 2021 | Q9C0D2 | |
| HSTDDPEAARSSNSK | 131 | Q9NUM3 | |
| LASIHTTKPENSSDD | 386 | Q8NG08 | |
| SDTQLEKIASHPAEQ | 371 | A6NMZ7 | |
| ESTNPEKAHETLHQS | 301 | P30304 | |
| SQDHQTPKQESSSSV | 1331 | Q12923 | |
| NQRSVDPADSTTTHK | 136 | Q3MIW9 | |
| HSTAAEEKTSPSQED | 146 | Q5THK1 | |
| SCENRSTSQPESVHK | 521 | Q92833 | |
| TPVHTTSQEKEEAQA | 286 | Q8IWE5 | |
| QKPTHEQREADSSSD | 906 | O14654 | |
| HQQESESEIDSVPKT | 276 | Q96PC5 | |
| SVPKTQSELASESEH | 286 | Q96PC5 | |
| HFSISKQNPSTREAE | 281 | P43121 | |
| KSPTSDDISLLHESQ | 6 | Q9Y3C5 | |
| QHTIASLSDQDAKPS | 256 | Q6P1K8 | |
| KHASESGDQPLVVNS | 1821 | O75445 | |
| QKASADTEHGPLTAQ | 176 | Q5M8T2 | |
| ENETLKHLTNDTTTP | 71 | Q9NWD8 | |
| SQQLHSASAEDTPVV | 461 | Q9Y6A5 | |
| QLKGQSQTSPDHRSD | 1056 | Q9UQ35 | |
| RSVSSQEEEHSSPVK | 216 | A4FU49 | |
| DEDSVHSPSSASQVK | 5081 | Q8WXH0 | |
| HKSNETSLPTDLNQT | 1071 | P12259 | |
| ANHVEKIELPNSTST | 406 | Q9UI40 | |
| RNNSLSKPDDSTEAH | 31 | Q9NSI8 | |
| HSPEQNEGSLTQTEK | 836 | Q5QGS0 | |
| VTLHATAQAPTDKNS | 661 | Q9NTG1 | |
| NHASDNIPKADEIRT | 101 | Q9Y248 | |
| VKTFQEDSSPVVHQS | 606 | Q15678 | |
| QDSNRSEKEATPVVH | 631 | Q9Y520 | |
| HSSPIALIDEKSTNA | 416 | Q5VXU9 | |
| HSESQPEKESRQSLA | 1216 | Q13796 | |
| DHLSKLNIPDTATET | 161 | Q92844 | |
| QTSEKTSSEEHLPQA | 866 | Q9P2P6 | |
| QVAEHVSSSNQEEPK | 2256 | Q9P2P6 | |
| EVTVHQKDQSSDATP | 346 | Q9P1W8 | |
| ASAHLTSQTAVDPEV | 561 | Q9NZP6 | |
| SPKQIHLDVDNDRTT | 946 | Q96QB1 | |
| PLKDTNSDEQHSTSA | 1141 | Q9UK61 | |
| KSTLNIPTEEQSHAR | 246 | P32247 | |
| SEHDQQAEESQSVPK | 336 | Q6ZVT6 | |
| TENSPADRSQKIHAG | 241 | G9CGD6 | |
| TENSPADRSQKIHAG | 241 | Q6P9H4 | |
| RSLSNTKPTVNEHDL | 416 | O75351 | |
| QDSKPVQHERIHSSE | 131 | P17039 | |
| VAAVQPSDNISRKHT | 111 | Q9Y2H5 | |
| NHLLNSSSKETEQPS | 946 | Q15468 | |
| KTVSQNQPDVSHTSR | 161 | Q9ULJ3 | |
| EFSSLEPSEQKSTVH | 386 | A4D1E1 | |
| NTKSDLHQNTVSIDP | 916 | P61129 | |
| ETSDPFSKLTQHQRI | 216 | Q8TB69 | |
| KTDRTTEPEQSHSNT | 356 | Q6GYQ0 | |
| KNHDLPATEVDASNI | 346 | Q96LT9 | |
| VLTRVHSNKPAQSDN | 336 | P40200 | |
| TRTASKNSAADLEHP | 1876 | Q96T58 | |
| PTTAHTKEDVDNSQI | 2061 | O60673 | |
| KARTPEGTHSQAQDT | 246 | A0A1B0GUW6 | |
| QHTIASLSDQDAKPS | 256 | Q13888 | |
| APKETDSSSNQRATH | 826 | Q9P2F5 | |
| TAEDSAQKTELQDPH | 596 | Q5T4T6 | |
| SPKDSQEDLQERHLS | 121 | Q6IPX3 | |
| LLEASPDHATSQQKR | 1901 | Q6ZS81 | |
| TSLDSDVPLQAATHK | 956 | Q9HCK1 | |
| LPEAGDSRVHNSTQK | 166 | Q9NPD8 | |
| LPVLQDSTNETTAHS | 6 | Q8WVM7 | |
| STQQEHEDAPSTKLQ | 696 | Q86UU1 | |
| SPKDSQEDLQERHLS | 121 | Q969E4 | |
| STEHTFSEQKDQEPT | 476 | P11137 | |
| CEKTLSHDSTTVQPQ | 456 | Q96NG8 | |
| KSNASTLESHETEEP | 471 | Q9UJA5 | |
| DTVFQVPQSSHSKEE | 746 | P59923 | |
| NPVVETHDSEASRQK | 36 | Q9UL58 | |
| SSDEQPASLTIAHVK | 226 | Q8N680 | |
| SITQQPSKHRTDEEL | 406 | Q9NYY3 | |
| ASQEEPLKSRVSHGN | 681 | Q9C0G0 | |
| KHNTHPTIEDISTQE | 176 | Q70CQ2 | |
| SSETSSQVLENHTKP | 346 | Q01831 | |
| SHTPALEQQTTSSEK | 1076 | Q6N021 | |
| LPSAKESASQHITEE | 466 | Q8IYH5 | |
| SSSQSEPNSNLEKIH | 221 | Q96RE9 | |
| DEPHISASVAVKQSS | 106 | Q14966 | |
| ISKHETEENSESQSP | 116 | Q6SJ96 | |
| SLPAVEKEQASTEHQ | 631 | Q14789 | |
| SSQHQTDKSEVPNAE | 621 | Q8WXR4 |